Friday, May 1, 2020

Looking at 'repurposing' drugs: Biocon

We are working to repurpose our novel monoclonal antibody Itolizumab
(used in psoriasis) to treat complications caused by Covid-19
infection. If we can successfully establish the potential role for our
molecule in treating Covid-19 complications, it will enable us to
address a critical unmet need, Kiran Mazumdar-Shaw said.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/looking-at-repurposing-drugs-biocon/articleshow/75501179.cms

No comments:

Post a Comment